Diabetes

  • A person sits in front of a plate of food, holding a smartphone. They're wearing a patch on their left arm.
    Image attribution tooltip
    Courtesy of Insulet Corp.
    Image attribution tooltip

    Insulet reports 18 serious adverse events with recall of Omnipod 5 insulin pumps

    The company is recalling certain lots of its insulin patch pumps after finding a small tear in the internal tubing may cause insulin to leak inside the pod.

    By • March 13, 2026
  • Professional photo of Ashley McEvoy
    Image attribution tooltip
    Permission granted by Insulet
    Image attribution tooltip

    Insulet posts clinical data on fully closed-loop insulin delivery system

    The company aims to start a pivotal trial this year, file for 510(k) clearance in 2027 and launch the device in 2028.

    By • March 12, 2026
  • Boston Scientific's Farapulse pulsed field ablation device. Explore the Trendline➔
    Image attribution tooltip
    Permission granted by Boston Scientific
    Image attribution tooltip
    Trendline

    New medical devices are reshaping the medtech industry

    From pulsed field ablation devices to glucose sensors and surgical robotics, new medical technologies are transforming patient care and how people manage their health.

    By MedTech Dive staff
  • Professional photo of Que Dallara
    Image attribution tooltip
    Permission granted by Medtronic
    Image attribution tooltip

    Medtronic’s MiniMed goes public for $560M

    The diabetes tech business is now operating as a standalone, public company. Shares began trading on Friday.

    By • March 6, 2026
  • FDA
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip

    FDA warns insulin infusion set maker Unomedical over leaks, mishandled complaints

    Unomedical, which supplies diabetes tech firms including Medtronic, Tandem Diabetes Care and Beta Bionics, received more than 5,000 complaints about leaking infusion sets between 2023 and 2025.

    By • March 2, 2026
  • A person sits on a couch with a white patch on their upper arm and a rectangular device with a screen on their hip.
    Image attribution tooltip
    Courtesy of Beta Bionics
    Image attribution tooltip

    FDA warns Beta Bionics on unreported complaints, insulin pump changes

    The Food and Drug Administration warning letter detailed unreported low blood sugar and a software change to correct for delayed glucose readings.

    By • Feb. 26, 2026
  • Professional photo of Jake Leach
    Image attribution tooltip
    Permission granted by Dexcom
    Image attribution tooltip

    AdvaMed names Jake Leach as chair of diabetes sector

    The Dexcom CEO will lead the lobbying group’s sector representing diabetes tech companies around the world.

    By • Feb. 24, 2026
  • Professional photo of Que Dallara
    Image attribution tooltip
    Permission granted by Medtronic
    Image attribution tooltip

    Medtronic’s MiniMed prices IPO at up to $784M

    The diabetes spinoff plans to offer 28 million shares at $25 to $28 each.

    By • Feb. 24, 2026
  • The exterior of Medtronic's Minnesota operational headquarters is shown along with its reflection in a pool of water.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic to cut 81 employees at California diabetes site

    As Medtronic prepares to spin out its diabetes business, a spokesperson said the company is considering the structure, capabilities and scale needed to succeed.

    By • Feb. 20, 2026
  • A black reader is shown on top of a phone with a blood glucose reading.
    Image attribution tooltip
    Permission granted by Senseonics
    Image attribution tooltip

    Senseonics launches automated insulin dosing system with 1-year CGM

    The company has integrated its Eversense 365 implant with Sequel Med Tech’s insulin delivery system to automate the management of Type 1 diabetes. 

    By • Feb. 20, 2026
  • Professional photo of Jake Leach
    Image attribution tooltip
    Permission granted by Dexcom
    Image attribution tooltip

    Dexcom seeks expanded Medicare coverage of CGMs for Type 2 diabetes

    New CEO Jake Leach said the company plans a trial readout in mid-2026 to support coverage of its glucose sensors in Type 2 users who don’t take insulin.

    By • Feb. 13, 2026
  • Medtronic's MiniMed 780G
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic wins expanded FDA label for 780G insulin pump

    The 510(k) decision clears the device for use with ultra-rapid-acting insulins from Eli Lilly and Novo Nordisk.

    By • Feb. 5, 2026
  • A person on a stationary bike wears a small, white patch on their upper arm.
    Image attribution tooltip
    Permission granted by Abbott Laboratories
    Image attribution tooltip

    Abbott receives FDA warning letter over Freestyle Libre CGMs

    Abbott needs to conduct more performance testing to ensure its FreeStyle Libre devices are accurate, FDA inspectors found.

    By • Feb. 3, 2026
  • A person sits on a couch with a white patch on their upper arm and a rectangular device with a screen on their hip.
    Image attribution tooltip
    Courtesy of Beta Bionics
    Image attribution tooltip

    Beta Bionics receives FDA warning letter

    The letter, which the FDA has not yet published, does not affect Beta Bionics’ ability to market, manufacture or distribute products, the company said.

    By • Feb. 2, 2026
  • A black reader is shown on top of a phone with a blood glucose reading.
    Image attribution tooltip
    Permission granted by Senseonics
    Image attribution tooltip

    Senseonics wins CE mark for one-year CGM

    The company is hiring sales reps and transitioning staff from its former partner to support launches in Germany, Italy, Spain and Sweden.

    By • Jan. 30, 2026
  • Modern glass and metal office building with a reflective blue-tinted facade, set against a clear blue sky. In the foreground, a large black and white sign reads “Abbott” with the company’s stylized logo and the number “645.” The area has neatly cut grass and a few small trees.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Abbott posts Q4 sales below expectations

    Pricing challenges in Abbott’s nutrition business and lower than expected sales of continuous glucose monitors drove down the company’s shares.

    By • Jan. 22, 2026
  • A person sits on a ledge with their legs in the water and eats. A patch is on their arm and a pen is on the ground next to food.
    Image attribution tooltip
    Permission granted by Medtronic
    Image attribution tooltip

    Medtronic gets FDA clearance for smart insulin pen app

    The app pairs Medtronic’s smart insulin pens with a sensor made by Abbott.

    By • Jan. 13, 2026
  • A person holds a phone, wearing a white patch on their forearm and an insulin pump on their hip.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic’s diabetes spinoff MiniMed files for IPO

    MiniMed is pitching the breadth of its portfolio as an advantage over more focused rivals such as Dexcom and Insulet.

    By • Dec. 22, 2025
  • A sign for the FDA is shown in front of the headquarters building in Silver Spring, Maryland.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    FDA pilots allowing digital health devices access to CMS payment program

    Companies can ask the FDA to waive premarket authorization and investigational device requirements while they collect real-world data in a CMS program.

    By • Dec. 10, 2025
  • The exterior of Medtronic's Minnesota operational headquarters is shown along with its reflection in a pool of water.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic changes investor relations leadership ahead of diabetes spinout

    Ryan Weispfenning has elected to take up the challenge of creating and leading the investor relations function at the planned new diabetes company.

    By • Dec. 9, 2025
  • A person stands outside wearing a small, square device with a cord on their belt.
    Image attribution tooltip
    Permission granted by Medtronic
    Image attribution tooltip

    Medtronic launches insulin delivery system with Abbott-made sensor

    The partnership is the first time Medtronic has integrated its insulin pumps with a sensor developed outside of the company.

    By • Dec. 3, 2025
  • CMS Administrator Dr. Mehmet Oz speaks at an Aspen Institute event.
    Image attribution tooltip
    Permission granted by Aspen Institute
    Image attribution tooltip

    CMS finalizes competitive bidding changes to diabetes devices

    AdvaMed supported adjustments made from a draft version but still has concerns about the impact on patient access.

    By • Dec. 1, 2025
  • A person wearing a white, round patch on their upper arm holds a phone.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    OIG report finds Medicare overpaying for CGMs and supplies

    The CMS could use its competitive bidding program to address price concerns, after payments for the devices swelled over five years, the government watchdog said.

    By • Nov. 26, 2025
  • A person on a stationary bike wears a small, white patch on their upper arm.
    Image attribution tooltip
    Permission granted by Abbott Laboratories
    Image attribution tooltip

    Abbott issues correction for millions of glucose sensors

    The problem applies to Abbott’s Libre 3 and Libre 3 Plus sensors. The company said it has received reports of 736 severe adverse events and seven deaths.

    By • Nov. 24, 2025
  • Professional photo of Ashley McEvoy
    Image attribution tooltip
    Permission granted by Insulet
    Image attribution tooltip

    Insulet unveils plans for new diabetes devices

    The medtech firm plans to launch its next flagship patch-pump in 2027, and its first fully closed loop system for Type 2 diabetes in 2028.

    By • Nov. 24, 2025
  • A picture of five Ōura smart rings against a gold background.
    Image attribution tooltip
    Courtesy of Ōura
    Image attribution tooltip

    Tidepool, Ōura partner on diabetes research

    The collaboration will pair biometric data from the Oura ring with information from glucose sensors and insulin pumps.

    By • Nov. 6, 2025